《接种新冠灭活病毒疫苗后发生神经视网膜炎 1 例》
A Case of Neuroretinitis following Inactivated Virion COVID-19 Vaccination.
机构信息
Institute of Ophthalmology, Jawaharlal Nehru Medical College, AMU, Aligarh, India.
Department of Pediatrics, Jawaharlal Nehru Medical College, AMU, Aligarh, India.
出版信息
Ocul Immunol Inflamm. 2023 Aug;31(6):1279-1282. doi: 10.1080/09273948.2023.2173244. Epub 2023 Feb 13.
PURPOSE
We report a rare presentation of neuroretinitis following vaccination with inactivated virion vaccine (COVAXIN).
METHODS
Interventional Case Report.
OBSERVATION
A 14-year-old female presented with sudden unilateral vision loss 3 days following COVID-19 vaccination. The clinical and radiological evaluation was consistent with classical neuroretinitis; the serological and immunological workup was negative. The patient responded well to the pulse steroid therapy and regained complete vision.
CONCLUSION
The COVID-19 vaccine related adverse ocular events are beginning to emerge slowly and thus warrants close monitoring of all such cases. Also, ophthalmologists should be encouraged to seek vaccination status of patients presenting with inflammatory ocular conditions.
目的
我们报告了一例在接种灭活病毒疫苗（COVAXIN）后出现神经视网膜炎的罕见病例。
方法
介入性病例报告。
观察
一名 14 岁女性在接种 COVID-19 疫苗后 3 天出现单侧突发性视力丧失。临床和影像学评估符合经典的神经视网膜炎；血清学和免疫学检查均为阴性。该患者对脉冲类固醇治疗反应良好，视力完全恢复。
结论
与 COVID-19 疫苗相关的眼部不良事件开始缓慢出现，因此需要密切监测所有此类病例。此外，应鼓励眼科医生询问出现炎症性眼部疾病的患者的疫苗接种情况。
Zotero 插件